Milestone Asset Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$249K Sell
4,585
-1,000
-18% -$45K 0.04% 216
2026
Q2
$235K Buy
+5,585
New +$178K 0.04% 246

Other funds holding ARKG

Milestone Asset Management's ARKG Position: Q3 2026 in Review

Milestone Asset Management reduced its ARK Genomic Revolution ETF (ARKG) stake by 18% in Q3 2026, selling an estimated $45K and leaving 4,585 shares worth $249K. The position accounts for 0.04% of the portfolio, ranked #216.

Milestone Asset Management first reported a position in ARKG in Q2 2026 and has held it in 2 quarters since. 316 funds tracked by Wall St. Rank hold ARKG as of Q3 2026.

  • Milestone Asset Management held 4,585 shares of ARK Genomic Revolution ETF worth $249K as of Q3 2026.
  • Milestone Asset Management sold 1,000 ARK Genomic Revolution ETF shares in Q3 2026, an estimated $45K.
  • ARK Genomic Revolution ETF made up 0.04% of Milestone Asset Management's portfolio in Q3 2026, its #216 holding.
  • Milestone Asset Management first reported a position in ARK Genomic Revolution ETF in Q2 2026 and has held it in 2 quarters since.
  • 316 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2026.

Based on Milestone Asset Management's 13F filing for Q3 2026, filed 15 Oct 2026.